dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Feng, Helian |
dc.contributor.author | Gusev, Alexander |
dc.contributor.author | Pasaniuc, Bogdan |
dc.contributor.author | Wu, Lang |
dc.contributor.author | Long, Jirong |
dc.contributor.author | Abu‐full, Zomoroda |
dc.contributor.author | Balmaña Gelpí, Judith |
dc.contributor.author | Diez Gibert, Orland |
dc.date.accessioned | 2021-10-22T09:04:05Z |
dc.date.available | 2021-10-22T09:04:05Z |
dc.date.issued | 2020-07 |
dc.identifier.citation | Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu‐full Z, et al. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status. Genet Epidemiol. 2020 Jul;44(5):442–468. |
dc.identifier.issn | 1098-2272 |
dc.identifier.uri | https://hdl.handle.net/11351/6445 |
dc.description | Subtipus de càncer de mama; Gen causal |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Genetic Epidemiology;44(5) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Aspectes genètics |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | Genetic Predisposition to Disease |
dc.title | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/gepi.22288 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | predisposición genética a la enfermedad |
dc.relation.publishversion | https://doi.org/10.1002/gepi.22288 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Feng H] Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. [Gusev A] Dana‐Farber Cancer Institute, Boston, Massachusetts. [Pasaniuc B] UCLA Path & Lab Med, Los Angeles, California. [Wu L] Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii. [Long J] Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt‐Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. [Abu-full Z] Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel. [Balmaña J] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Diez O] Hereditary Cancer Genetics Group, Area of Clinical and Molecular Genetics, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32115800 |
dc.identifier.wos | 000517111500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |